Inventor · disambiguated record
Motowo Nakajima
Also filed as: NAKAJIMA MOTOWO
25 granted patents·16 pending applications·242 citations·filing 1987–2024
94Inventor score
Top patents by PatentIndex Score
41 records- 0186US4859581AEndoglycosidase assayUNIV TEXAS·Filed 1987·Granted Aug 22, 1989·57 cites·22 claims
- 0282US9012502B2Cancer heat therapy-enhancing agentCHIBAZAKURA TAKU·Filed 2011·Granted Apr 21, 2015·15 cites·5 claims
- 0380US5332812ASolid-phase substrate containing modified heparinUNIV TEXAS·Filed 1991·Granted Jul 26, 1994·50 cites·30 claims
- 0479US9399029B2Immune tolerance inducerSBI PHARMACEUTICALS CO LTD·Filed 2013·Granted Jul 26, 2016·5 cites·20 claims
- 0578US9314443B2Enhancer of survival of transplanted organRII KO·Filed 2012·Granted Apr 19, 2016·4 cites·16 claims
- 0678US5262403AGlycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-IIUNIV TEXAS·Filed 1990·Granted Nov 16, 1993·51 cites·11 claims
- 0776US6277987B1Sulfonylamino acid and sulfonylamino hydroxamic acid derivativesNOVARTIS AG·Filed 1999·Granted Aug 21, 2001·49 cites·23 claims
- 0870US9089530B2Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredientTANAKA TOHRU·Filed 2011·Granted Jul 28, 2015·2 cites·7 claims
- 0969US9351949B2Prophylactic/therapeutic agent for influenza virus infectionSBI PHARMACEUTICALS CO LTD·Filed 2013·Granted May 31, 2016·2 cites·8 claims
- 1069US2022370395A1Enhancer of photodynamic effect in ala-pdt or ala-pddSBI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1166US7138432B1Arylsulfonamido-substituted hydroxamic acid derivativesNOVARTIS AG·Filed 2000·Granted Nov 21, 2006·3 cites·20 claims
- 1266US2025382338A1Agent for reducing endotoxin in proteoglycans derived from animal tissues, and method for producing proteoglycanNAT UNIV CORP TOTTORI UNIV·Filed 2024·Application pending·0 cites
- 1358US2020030275A1Enhancer of photodynamic effect in ala-pdt or ala-pddSBI PHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
- 1455US8034810B2Arylsulfonamido-substituted hydroxamic acid derivativesNOVARTIS AG·Filed 2006·Granted Oct 11, 2011·0 cites·12 claims
- 1554US2024189269A1Pharmaceutical composition for suppressing tmprss2 expressionTOKYO INST TECH·Filed 2021·Application pending·0 cites
- 1652US9962350B2Agent for improving normal development rate of fertilized eggsSBI PHARMACEUTICALS CO LTD·Filed 2015·Granted May 8, 2018·0 cites·10 claims
- 1752US9937138B2Enhancer of survival of transplanted organSBI PHARMACEUTICALS CO LTD·Filed 2016·Granted Apr 10, 2018·0 cites·16 claims
- 1852US9901558B2Enhancer of survival of transplanted organSBI PHARMACEUTICALS CO LTD·Filed 2016·Granted Feb 27, 2018·0 cites·9 claims
- 1951US2012277246A1Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic DisordersHEINRICH MICHAEL·Filed 2012·Application pending·0 cites
- 2049US9469598B2Erythropoietin production-promoting agentSBI PHARMACEUTICALS CO LTD·Filed 2012·Granted Oct 18, 2016·0 cites·14 claims
- 2149US2011201619A1Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic DisordersHEINRICH MICHAEL·Filed 2011·Application pending·0 cites
- 2247US10022345B2Agent for preventing and/or treating veisalgiaSBI PHARMACEUTICALS CO LTD·Filed 2015·Granted Jul 17, 2018·0 cites·20 claims
- 2347US9488664B2Diagnostic agent for tumorSBI PHARMACEUTICALS CO LTD·Filed 2013·Granted Nov 8, 2016·0 cites·20 claims
- 2447US2014343140A1Agent for Preventing and/or Treating VeisalgiaSBI PHARMACEUTICALS CO LTD·Filed 2012·Application pending·0 cites
- 2546US9474770B2Prophylactic agent and/or therapeutic agent for sepsisKINOSHITA KOSAKU·Filed 2012·Granted Oct 25, 2016·0 cites·15 claims
- 2646US2010144750A1Use of N-Phenyl-2-Pyrimidineamine Derivatives Against Mast Cell-Based Diseases Like Allergic DisordersHEINRICH MICHAEL·Filed 2010·Application pending·0 cites
- 2746US2004157855A1Use of n-phenyl-2-pyrimidineamine derivativea against mast cell-based diseases like allergic disordersFiled 2002·Application pending·0 cites
- 2844US9895331B2Prophylactic and/or therapeutic agent for radiation damageUNIV TOKYO·Filed 2013·Granted Feb 20, 2018·0 cites·16 claims
- 2944US9463175B2Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredientSBI PHARMACEUTICALS CO LTD·Filed 2015·Granted Oct 11, 2016·0 cites·8 claims
- 3044US6410580B1Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinasesNOVARTIS AG·Filed 1999·Granted Jun 25, 2002·3 cites·14 claims
- 3144US2015038837A1Device for determining metastasis of cancer to sentinel lymph nodeSBI PHARMACEUTICALS CO LTD·Filed 2013·Application pending·0 cites
- 3243US2015238085A1Photodynamic diagnosis apparatus provided with collimatorSBI PHARMACEUTICALS CO LTD·Filed 2013·Application pending·0 cites
- 3343US2018125805A1Prophylactic/therapeutic agent for virus infections which comprises ala compoundSBI PHARMACEUTICALS CO LTD·Filed 2016·Application pending·0 cites
- 3442US9539225B2Anemia of cancer improving/prophylactic agentSBI PHARMACEUTICALS CO LTD·Filed 2012·Granted Jan 10, 2017·0 cites·10 claims
- 3540US9475755B2Prophylactic agent for chronic kidney diseaseSBI PHARMACEUTICALS CO LTD·Filed 2012·Granted Oct 25, 2016·0 cites·10 claims
- 3640US2016271090A1Frataxin enhancerUNIV TOKYO AGRICULTURE·Filed 2014·Application pending·0 cites
- 3738US2017202210A1Organ preservation solutionSBI PHARMACEUTICALS CO LTD·Filed 2015·Application pending·0 cites
- 3837US9707196B2Treatment agent and/or prophylactic agent for side effects of cancer drugsSBI PHARMACEUTICALS CO LTD·Filed 2012·Granted Jul 18, 2017·0 cites·4 claims
- 3935US2002115183A1Human heparanase polypeptide and cDNAFiled 2002·Application pending·0 cites
- 4035US2005232915A1Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancerNAKAJIMA MOTOWO·Filed 2003·Application pending·0 cites
- 4127US6461848B1Human heparanase polypeptide and cDNANOVARTIS AG·Filed 1999·Granted Oct 8, 2002·1 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Motowo Nakajima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →